|
MARCH 10-12, 2026 | RALEIGH, NC |
* Denotes Innovation Award Winner
Direct de novo sequencing of therapeutic RNA and impurities via next-generation mass spectrometry
3D NGMS-Seq is a new tool that reads RNA molecules directly and accurately, even when they're mixed or modified. Unlike older methods, it doesn’t need a reference sequence. It uses advanced mass measurements and smart algorithms to uncover hidden RNA variants, helping improve RNA-based drug development and quality control.Regenerative Breast Tissue
Regenerative Breast Tissue is a 3D bioprinted scaffold combined with the patient’s own fat cells during surgery. Made from a soft, pliable biomaterial that feels like natural breast tissue, the scaffold promotes natural tissue regeneration while safely degrading, leaving behind the patient’s regenerated tissue for a natural, long-lasting reconstruction.Ambient Intelligent Modular Rack Guidance System
Voice-activated guidance system that transforms ordinary storage racks into intelligent nodes. Using simple commands and dynamic lighting, it instantly directs users to the right item, cutting search time from minutes to seconds. This retrofit approach streamlines workflows, relieves stress, and improves patient outcomes and efficiency across hospitals at scale.An efficient monitoring tool for chronic wounds and pressure ulcers
A handheld photoacoustic imaging probe to spot assess oxygenation of wounds/ischemic tissueMelodiaSync: Enhancing Cognitive Performance by an EEG-Guided Audio Neuromodulation System
MelodiaSync® reads brainwaves with a lightweight EEG headset and delivers adaptive binaural audio in real time to shift into a desired brain state—calm or focus, in minutes. It is a closed‑loop system that personalizes itself on the fly for reliable, repeatable effects.RapiSep: A Plasma Separator Enabling Rapid and Decentralized Blood Processing and Diagnostics
A reagent-less, equipment and electricity-free blood/plasma preparation technology with simple operation (sip, tap, cap) to obtain high-quality plasma in just one minuteIV cNP8 (Phase 2 Clinical Trial)
IV cNP8 utilizes a peptide (cNP8) engineered to speed healing, minimize scarring, and reduce pain in acute burn wounds. cNP8 can be injected IV at 0.001-0.03mg/kg into the patient at 12-48 hours post-burn. cNP8 can be used to treat burns in prolonged casualty care (PCC) scenariosLong-lasting, reversible on demand, non-hormonal male contraceptive
Plan A is a hydrogel that blocks sperm in the vas deferens using a simple painless procedure that can be easily reversed in office.Smart Pneumatic Tourniquet for Field Hemorrhage Control
A dual-use portable, intelligent device that stops severe bleeding by applying precisely controlled pressure to wounded areas. Built-in sensors automatically track safe pressure levels and time, reducing errors and saving lives and limbs in remote or austere combat situations where advanced care or hospitals aren’t immediately available.RealNose: AI-Powered Bioelectronic Scent Detection Platform
RealNose digitizes smell using stabilized mammalian olfactory receptors and AI signal processing to detect scent signatures conferred by volatile organic compounds (VOCs). This platform enables scalable, non-invasive biosensing for disease diagnostics, biomanufacturing process monitoring, and biosurveillance, allowing for early, precise detection across healthcare and bioindustrial applications.DEVA- Decellularized Engineered Vascularized Allograft
A shelf-stable, off-the-shelf skin substitute engineered with preserved blood vessel structures and antimicrobial nanoparticles. DEVA helps chronic and burn wounds heal faster by integrating better with patient tissue, reducing infection risk, and eliminating the need for cold storage.Fungal Sphaeropsidin A for Refractory Cancer
We engineered effective anticancer agents derived from a fungal natural product to treat chemotherapy resistance, a massive clinical and economic burden. By forcing resistant cancer cells to reduce volume, this novel mechanism overcomes treatment failure. These agents offer a safer and more effective therapeutic option for patients.Enhanced Lubrication and Anti-inflammation Treatment for Articular and Artificial Joints
Our invention dramatically improves the performance and longevity of natural and artificial joints by using nanoscale diamond particles as a lubricant additive. The approach is compatible with both articular cartilage and a wide range of joint materials and helps reduce bacterial growth, making implants safer and more durable for patients.SPONSORS & PARTNERS
SUPPORTING ORGANIZATIONS
2026 FEDERAL PARTNERS
About
Committees
Media
Venue and Lodging
Co-Located Events
Terms and Conditions
Visas and Invitational Letters
Instructions For Technical Presenters
Contact
Full Program
Business Program
Innovation Pitch Programs
Sectors
Speakers
Technical Symposia
Student Programs
EMC2 & LEAN Power Network Industry Day /a>
SBIR/STTR Innovator Training Workshop
© Copyright 2026 TechConnect. All Rights Reserved. Disclaimer | Privacy Policy | Terms of Use